Search concepts
|
Selected filters
|
- 550 - 600 out of 7,513 results
Search results
-
Answering longstanding plant ecology questions with new technology: the effects of changes in leaf proteins with age
Westoby, M., Van Sluyter, S., Haynes, P., Gygi, S. P. & MQRES (International), M. (.
1/01/14 → …
Project: Research
-
Antenna response of gamma-irradiated Queensland fruit flies
Weldon, C., Collins, S. & Taylor, P.
1/01/10 → 31/12/10
Project: Research
-
Antennas and Other Electromagnetic Components for Wireless-Enabled Complex Systems
12/02/11 → 29/07/11
Project: Research
-
-
Antibiotic resistance: combining microscopy, microfluidics and genomics to target bacterial DNA repair pathways
Robinson, A., Paulsen, I. & Jin, D.
1/01/19 → 31/12/21
Project: Other
-
Antibiotic resistance and the ecological effects of selective decontamination of the digestive tract in Intensive Care Units
Paulsen, I., Iredell, J., Partridge, S., Darling, A. & Seppelt, I.
1/01/17 → …
Project: Research
-
Antimicrobial compounds from the model marsupial, the Tammar wallaby (Macropus eugenii )
Ambatipudi, S.
1/07/06 → 30/06/08
Project: Research
-
Ant inspired rules for self-assembly in swarm robotics and complex systems
1/05/19 → 30/04/22
Project: Research
-
ACARP: Antiochia ad Cragum Archaeological Research Project
Dodd, E. & Hoff, M.
1/06/14 → …
Project: Research
-
AntiPort - Educating the Public on the risks and prevention of Mobile Number Porting Scams
Trueck, S., Selby, J., Doche, C. & Boyd, M.
1/02/19 → 31/12/20
Project: Research
-
USYD Lifespan Seed Grants Program: Anxiety and alcohol use during the transition to young adulthood: Can we re-train the brain?
Prior, K., Stapinski, L., Wiers, R., Mahoney, A., Curtis, J., Salemink, E., Teachman, B., Newton, N., Teesson, M., Baillie, A., Deady, M., McLellan, L., Mewton, L. & Lees, B.
15/04/19 → 16/12/19
Project: Research
-
Anywhere Working (Telework) and Telehealth Delivery: Productivity, Wellbeing and Service Quality
Blount, Y., Markey, R. & Gloet, M.
1/01/14 → 31/12/15
Project: Research
-
A PRIORI: Aortix Therapy for Perioperative Reduction of Renal Injury (A PRIORI)
Worthley, S., Chapman, N. & Chester, C.
9/05/22 → 28/04/27
Project: Research
-
-
APECS determination of Auger parameters of C and Si
Thurgate, S. & van Rissen, G.
23/04/07 → 25/04/07
Project: Research
-
-
A Personalized Social Network Based Location Search and Recommender System
Yang, J., Orgun, M., Wang, Y., Air, M., Eichhorn, B. & Rej, T.
1/05/13 → …
Project: Research
-
A Pharmacological Targeting Approach Implementing Albumin as a Carrier of a Novel Chemotherapeutic
Lovejoy, D., Kalinowski, D., Rahmanto, Y. & Ponka, P.
1/01/13 → 31/12/15
Project: Research
-
ADG116-1003: A Phase 1, Open-Label, Dose Escalation Study of ADG116 in Patients with Advanced/Metastatic Solid Tumors
Park, J., Chapman, N. & Sabanathan, D.
14/09/20 → 27/08/25
Project: Research
-
Y-biologics: A Phase 1, Open-Label, Multicenter, Single Arm, Dose-Escalation/Dose-Expansion Study of YBL-006 in Patients with Advanced Solid Tumors
Sabanathan, D., Park, J., Gurney, H., Chapman, N. & Rai, M.
1/06/20 → 30/04/23
Project: Research
-
CS3002-101: A phase 1, open-label, multi-dose, dose escalation and expansion study to investigate the safety, tolerability, pharmacokinetics and anti-tumor activities of CS3002, a CDK4/6 inhibitor, in subjects with advance solid tumors
Park, J., Sabanathan, D. & Chapman, N.
30/10/20 → 24/09/25
Project: Research
-
SBT6050-1001: A Phase 1/1b, Open Label, Dose Escalation and Expansion Study of SBT6050 in Patients with Advanced Solid Tumors Expressing HER2
Sabanathan, D., Park, J. & Chapman, N.
2/09/20 → 27/08/25
Project: Research
-
LYT-100-2020-01: A Phase 1/1b Multiple Ascending Dose and Food Effect Study in Healthy Volunteers to Determine the Pharmacokinetics and Maximally Tolerated Dose of Deupirfenidone (LYT-100) Followed by Further Exploration in Patients with Breast Cancer-Related Upper Limb Secondary Lymphoedema
Mackie, H., Koelmeyer, L. A., Chapman, N. & Rai, M.
1/08/20 → 25/06/25
Project: Research
-
AB928CSP0002: A Phase 1/1b Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants with Breast or Gynecologic Malignancies
Sabanathan, D., Kefford, R., Cunningham, J. & Butala, R.
6/12/18 → 9/04/21
Project: Other
-
A phase 1/2 open label, multi-center dose escalation and expansion study of combination immunotherapy CBT-501 (anti-PD-1) or nivolumab with CBT-101 (c-Met inhibitor) in locally advanced or metastatic hepatocellular carcinoma and renal cell carcinoma
Sabanathan, D., Chapman, N., Butala, R. & Gurney, H.
16/05/19 → 15/05/24
Project: Other
-
A phase 1/2 open label, multi-center dose escalation and expansion study of combination immunotherapy CBT-501 (anti-PD-1) or nivolumab with CBT-101 (c-Met inhibitor) in locally advanced or metastatic hepatocellular carcinoma and renal cell carcinoma
Sabanathan, D., Chapman, N., Butala, R. & Gurney, H.
16/05/19 → 15/05/24
Project: Other
-
A Phase 1B, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Ipatasertib in Combination with Rucaparib in patients with Advanced Breast, Ovarian, or Prostate Cancer
Gurney, H., Chapman, N. & Butala, R.
5/08/19 → 26/06/24
Project: Other
-
A Phase 1B/2 study to evaluate safety and anti-tumour activity of AVELUMAB in combination with POLY (ADENOSINE DIPHOSPHATE [ADP]-RIBOSE) POLYMERASE (PARP) inhibitor TALAZOPARIB in patients with locally advance or metastatic solid tumours
Sabanathan, D., Kefford, R., Butala, R. & Cunningham, J.
19/07/18 → 5/01/21
Project: Research
-
XL184-021: A Phase 1b Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab to Subjects with Locally Advanced or Metastatic Solid Tumors
Park, J., Sabanathan, D., Gurney, H., Chapman, N. & Rai, M.
28/08/20 → 30/04/25
Project: Research
-
MT-5111_001: A Phase 1b Open-label, Multicenter Dose Escalation and Expansion Study of MT-5111 in Subjects With Previously Treated Advanced HER2-positive Solid Tumors
Sabanathan, D., Park, J. & Chapman, N.
13/12/21 → 12/12/26
Project: Research
-
C0541001: A PHASE 1 DOSE ESCALATION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF PF 06804103 IN PATIENTS WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) POSITIVE AND NEGATIVEe SOLID TUMORS
Sabanathan, D. & Chapman, N.
21/09/20 → 31/05/25
Project: Research
-
ZN-c5-002: A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects with EstrogenReceptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
Sabanathan, D., Park, J. & Chapman, N.
15/10/20 → 23/07/21
Project: Research
-
Harbour Biomed 4003.1: A Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of HBM4003 in Subjects with Advanced Solid Tumors
Gurney, H., Chapman, N., Butala, R., Parshionikar, A. & Rajasekharan Nair, A.
30/09/19 → 30/09/24
Project: Other
-
HP518-CS-001: A Phase 1 open-label study to assess the safety, pharmacokinetics and anti-tumor activity of oral HP518 in patients with metastatic castration-resistant prostate cancer
Gurney, H. & Chapman, N.
17/01/22 → 13/12/26
Project: Research
-
MISC_Covance Chiltern: A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting Programmed Death Ligand 1 (PD-L1) Protein in Patients with Advanced Solid Tumors
Gurney, H., Butala, R. & Cunningham, J.
16/07/18 → 15/07/23
Project: Other
-
CYCLONE 2: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer
Gurney, H., Chapman, N., Cunningham, J. & Butala, R.
1/12/18 → 30/11/23
Project: Other
-
GALAXI: A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease
Leong, R., Butala, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.
30/09/19 → 7/05/24
Project: Research
-
APOLLO-CD: A Phase 2a, Multi-Center, Open-Label Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of PRA023 in Subjects with Moderately to Severely Active Crohn’s Disease
Leong, R. & Chapman, N.
8/02/22 → 28/07/26
Project: Research
-
VEGA: A Phase 2a Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Proof-of-concept Clinical Study to Evaluate the Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Leong, R., Butala, R. & Chapman, N.
24/09/19 → 11/07/24
Project: Other
-
A Phase 2 Efficacy and Safety Study of Niraparib in Men with Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Gurney, H., Cunningham, J. & Butala, R.
17/10/18 → 4/09/23
Project: Other
-
ACT16849: A Phase 2 non-randomized, open-label, multi-cohort, multi-center study assessing the clinical benefit of SAR444245 (THOR-707) combined with other anticancer therapies for the treatment of participants with lung cancer or pleural mesothelioma
Park, J., Chapman, N. & Tan, P.
13/05/21 → 15/04/26
Project: Research
-
A Phase 2 Open Label Trial of 3K3A-APC in Amyotrophic Lateral Sclerosis.
Rowe, D., Gan, R. & Ordonez Artunduaga, P.
Project: Research
File -
GS-US-548-5916: A Phase 2 Study of Magrolimab Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma
Park, J., Sabanathan, D., Xia, C. Y., Kim, S. & Chapman, N.
3/08/21 → 29/07/26
Project: Research
-
A Phase 3, multicenter, randomized, open-label, active-controlled study of DS-8201a, an anti-HER2-antibody drug conjugate, versus treatment of investigator’s choice for HER2-positive, unresectable and/or metastatic breast cancer subjects pretreated with prior standard of care HER2 therapies, including T-DM1
Kefford, R., Butala, R. & Cunningham, J.
12/03/19 → 25/11/23
Project: Other
-
ADVANCE capacity: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by Cardiopulmonary Exercise Testing in Subjects with World Health Organization Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
Brown, M., Chapman, N., Rai, M. & Parshionikar, A.
1/07/20 → 31/03/25
Project: Research